Jpmorgan Chase & CO Procaps Group, S.A. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$2.18 - $4.14 $1,624 - $3,084	745 New	745 $3,000
Q2 2023 Aug 11, 2023	BUY	$3.84 - $5.04 $1,167 - $1,532	304 New	304 $1,000
Q4 2021 Feb 10, 2022	SELL	$8.85 - $10.42 $222,188 - $261,604	-25,106 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$9.25 - $10.76 $232,230 - $270,140	25,106 New	25,106 $256,000

195K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $196M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.